Patents for C12P 21 - Preparation of peptides or proteins (112,499)
11/2002
11/27/2002EP1259612A2 G-protein coupled receptor related polypeptides
11/27/2002EP1259611A2 G-protein coupled receptors
11/27/2002EP1259609A2 Human schizophrenia gene
11/27/2002EP1259606A2 Compositions useful for regulating parkin gene activity
11/27/2002EP1259595A2 Integrin antagonists
11/27/2002EP1259547A2 High potency recombinant antibodies and method for producing them
11/27/2002EP1259540A1 Nucleic acids, proteins, and antibodies
11/27/2002EP1259531A2 Nucleic acids, proteins, and antibodies
11/27/2002EP1259530A1 Melanoma differentiation associated gene - 5 and promoter and uses thereof
11/27/2002EP1259527A1 35 human secreted proteins
11/27/2002EP1259526A2 Nucleic acids, proteins, and antibodies
11/27/2002EP1259525A1 Serine/threonine phosphatase polynucleotides, polypeptides, and antibodies
11/27/2002EP1259251A2 Novel method for down-regulation of amyloid
11/27/2002EP1259247A1 DNA ENCODING HUMAN ACID-SENSING ION CHANNEL BNaC4 (ASIC4)
11/27/2002EP1259223A1 Protein matrix materials, devices and methods of making and using thereof
11/27/2002EP1019504A4 Isoforms of the human vitamin d receptor
11/27/2002EP0876500A4 Cold-active protease cp70
11/27/2002EP0700402B1 Methods and materials for modulation of the immunosuppressive activity and toxicity of monoclonal antibodies
11/27/2002EP0608261B1 Immunoreactive hepatitis c virus polypeptide compositions
11/27/2002CN1382259A Improved method for detection of acid resistant microorganisms in stool
11/27/2002CN1382216A DNA coding for beta-tubulin and use thereof
11/27/2002CN1382214A Novel protein derived from agkistrodon saxatilis emelianov and process for preparing the same
11/27/2002CN1382158A Multiple cytokine-antibody complexes
11/27/2002CN1382153A 重组亚单位疫苗 Recombinant subunit vaccine
11/27/2002CN1381500A Polypeptide-human macroprotien -49.61 and polynucleotide for coding it
11/27/2002CN1381499A Polypeptide-human G protein coupling receptor -9.57 and polynucleotide for coding it
11/27/2002CN1381498A Polypeptide-DNA bad damage repair protein -10.45 and polynucleotide for coding it
11/27/2002CN1381497A Polypeptide-human macroprotein -64.79 and polynucleotide for coding it
11/27/2002CN1381496A Polypeptide-human tyrosine kinase substrate-38.39 and polynucleotide for coding it
11/27/2002CN1381495A Polypeptide-human myelin development regulation protein -35.86 and polynucleotide for coding it
11/27/2002CN1381494A Polypeptide-human actin binding factor-46.31 and polynuceotide for coding it
11/27/2002CN1381493A Polypeptide-human protein -9.9 containing uterus globulin function domain and polynucleotide for coding it
11/27/2002CN1381492A Polypeptide-human rebosomal protein -8.91 and polynucleotide for coding it
11/27/2002CN1381491A Polypeptide-human retinoic acid inducer protein -19.58 and polynucleotide for coding it
11/27/2002CN1381490A Polypeptide-interferon inducer protein -32.34 and polynucleotide for coding it
11/27/2002CN1381489A Polypeptide-human macroprotein-54.89 and polynucleotide for coding it
11/27/2002CN1381488A Polypeptide-distal upstream element bindin 38.83 and polynucleotide for coding it
11/27/2002CN1381487A Polypeptide-human protein-46.53 containing bromo structure domain and polynucleotide for coding it
11/27/2002CN1381486A Polypeptide-human zinc finger protein-61.82 and polynucleotide for coding it
11/27/2002CN1381485A Polypeptide-human macroprotein-27.28 and polynucelotide for coding it
11/27/2002CN1381484A Polypeptide-human macroprotein-71.83 and polynucleotide for coding it
11/27/2002CN1381483A Polypeptide-human sperm generation associated factor-86.90 and polynucleotide for coding it
11/27/2002CN1381482A Polypeptide-clathrin light chain -9.02 and polynucleotide for coding it
11/27/2002CN1381481A Polypeptide-human macroprotein -14.96 and polynucleotide for coding it
11/27/2002CN1381480A Polypeptide-synapsin-9.57 and polynucleotide for coding it
11/27/2002CN1381479A Polypeptide-human herpesvirus-23.43 and polynucleotide for coding it
11/27/2002CN1381478A Polypeptide-ribosome S7 protein -11.77 and polynucleotide for coding it
11/27/2002CN1381477A Polypeptide-human immunologlobulin light chain protein -26.40 and polynucleotide for coding it
11/27/2002CN1381476A Polypeptide-human tumor endothelial marker -30.69 and polynucleotide for coding it
11/27/2002CN1381475A Polypeptide-ribosomal protein L39-12.32 and polynucleotide for coding it
11/27/2002CN1381474A Polypeptide-human nucleoporin -39.6 and polynucleotide for coding it
11/27/2002CN1381473A Polypeptide-human macroprotein -46.53 and polynucleotide for coding it
11/27/2002CN1381472A Polypeptide-replication protein A interactino protein alpha-24.09 and polynucleotide for coding it
11/27/2002CN1381471A Polypeptide-human ferroheme Cu-ion respiration oxidase sub-unit-17.27 and polynucleotide for coding it
11/27/2002CN1381470A Polypeptide-human Na-ion K-ion channel inhibitor-52.25 and polynucleotide for coding it
11/27/2002CN1381469A Polypeptide-protein kinase 2 structure domain -23.43 and polynucleotide for coding it
11/27/2002CN1381468A Polypeptide-human erythrocytic kytoplasma protein-8.8 and polynucleotide for coding it
11/27/2002CN1381467A Polypeptide-human zinc finger protein-32.56 and polynucleotide for coding it
11/27/2002CN1381465A Gene configuration, preparing process and usage of antibacterial peptide
11/27/2002CN1094976C Tomato spotted wilt virus
11/26/2002US6486305 Method of modulating the efficiency of translation termination and degradation of aberrant mrna involving a surveillance complex comprising human upf1p, eucaryotic release factor 1 and eucaryotic release factor 3
11/26/2002US6486131 As diagnostic and therapeutic assays and reagents for detecting and therapy of proliferative disorders arising from, for example, tumorigenic transformation of cells, or other hyperplastic or neoplastic transformation processes
11/26/2002US6486123 Low oxygen affinity mutant hemoglobins
11/26/2002US6485977 Recombinant constructs and techniques for delivering to eucaryotic cells bacterial proteins that are secreted via type III secretion systems
11/26/2002US6485970 Immunointeractive antibody
11/26/2002US6485968 Ectoparasite saliva proteins and apparatus to collect such proteins
11/26/2002US6485960 Polycystic kidney disease 1 gene and uses thereof
11/26/2002US6485957 DNA encoding the human serine protease EOS
11/26/2002US6485936 Heat shock transcription factor-binding protein
11/26/2002US6485935 Structure of the ankyrin binding domain of a α-Na, K-ATPase
11/26/2002US6485934 Regulatory system for inducible expression of genes with lambdoid promoters
11/26/2002US6485930 Mannosyl transfer with regeneration of GDP-mannose
11/26/2002US6485919 Human metabotropic glutamate receptors, nucleic acids encoding same and uses thereof
11/26/2002US6485914 Method of detecting chlamydia pneumoniae gene using polynucleotides
11/26/2002US6485904 DNA encoding a plasminogen activating protein
11/26/2002CA2228635C Mammalian apoptosis inhibitor protein gene family, primers, probes and detection methods
11/26/2002CA2111573C Cadherin materials and methods
11/26/2002CA2107672C Peptides and mixtures thereof for detecting antibodies to hepatitis c virus (hcv)
11/26/2002CA2098838C Liver enriched transcription factor
11/26/2002CA1341401C Immunosuppressant factor derived from human glioblastoma cells
11/21/2002WO2002092842A2 Nucleic acids and corresponsing proteins entitled 101p3a11 or phor-1 useful in treatment and detection of cancer
11/21/2002WO2002092841A2 Nucleic acid molecules encoding a transmembrane serine protease 10, the encoded polypeptides and methods based thereon
11/21/2002WO2002092832A2 Human and non-human primate homologues of nkd protein, nucleic acid sequences encoding, and uses thereof
11/21/2002WO2002092829A1 Process for producing peptide
11/21/2002WO2002092827A2 Corona-virus-like particles comprising functionally deleted genomes
11/21/2002WO2002092819A1 A variable region of the monoclonal antibody against the hbv s-surface antigen and a gene encoding the same
11/21/2002WO2002092812A1 ARTIFICIAL HUMAN CHROMOSOME CONTAINING HUMAN ANTIBODY μ LIGHT CHAIN GENE
11/21/2002WO2002092801A2 Methods and compositions for making emamectin
11/21/2002WO2002092782A2 Diagnosis and treatment of malignant neoplasms
11/21/2002WO2002092771A2 Specific binding proteins and uses thereof
11/21/2002WO2002092764A2 Transgenic animal model of bone mass modulation
11/21/2002WO2002092762A2 Cytokine polypeptides
11/21/2002WO2002092759A2 Molecules for disease detection and treatment
11/21/2002WO2002092758A2 Gastrokines and derived peptides including inhibitors
11/21/2002WO2002092625A2 Moraxella(branhamella) catarrhalis antigens
11/21/2002WO2002092135A1 Methods of using labelled verotoxin b subunit
11/21/2002WO2002092118A1 Global analysis of protein activities using proteome chips
11/21/2002WO2002092004A2 Use of hmg fragment as anti-inflammatory agents
11/21/2002WO2002092000A2 Hbm variants that modulate bone mass and lipid levels
11/21/2002WO2002091995A2 Method to induce neovascular formation and tissue regeneration